HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China
· Delayed Price · Currency is CNY 2.490
-0.010 (-0.40%)
Apr 29, 2025, 2:45 PM CST
SHE:002437 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 5,570 | 5,677 | 5,517 | 5,583 | 6,397 | 7,034 | Upgrade
|
| Market Cap Growth | 14.01% | 2.89% | -1.18% | -12.72% | -9.06% | 5.61% | Upgrade
|
| Enterprise Value | 5,064 | 5,277 | 5,430 | 5,794 | 6,481 | 7,718 | Upgrade
|
| Last Close Price | 2.48 | 2.49 | 2.51 | 2.54 | 2.91 | 3.20 | Upgrade
|
| PE Ratio | 23.41 | 24.39 | 45.85 | - | 142.01 | 17.58 | Upgrade
|
| Forward PE | 24.80 | 24.55 | 24.55 | 24.55 | 24.55 | 24.55 | Upgrade
|
| PS Ratio | 2.32 | 2.33 | 2.10 | 1.80 | 2.03 | 2.30 | Upgrade
|
| PB Ratio | 2.84 | 2.88 | 3.23 | 3.28 | 3.23 | 3.64 | Upgrade
|
| P/TBV Ratio | 4.05 | 4.01 | 5.01 | 5.36 | 5.36 | 6.48 | Upgrade
|
| P/FCF Ratio | 18.45 | 16.31 | 22.56 | 24.42 | 26.69 | - | Upgrade
|
| P/OCF Ratio | 15.55 | 13.81 | 20.12 | 21.34 | 23.33 | 551.09 | Upgrade
|
| PEG Ratio | - | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | Upgrade
|
| EV/Sales Ratio | 2.11 | 2.16 | 2.07 | 1.86 | 2.06 | 2.53 | Upgrade
|
| EV/EBITDA Ratio | 13.88 | 13.75 | 19.70 | 26.87 | 25.45 | 1727.71 | Upgrade
|
| EV/EBIT Ratio | 18.47 | 18.04 | 31.57 | 67.68 | 56.03 | - | Upgrade
|
| EV/FCF Ratio | 16.78 | 15.16 | 22.20 | 25.35 | 27.04 | - | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.00 | 0.40 | 0.85 | 0.79 | 0.70 | Upgrade
|
| Debt / EBITDA Ratio | 0.20 | 0.01 | 2.45 | 6.75 | 5.99 | 302.75 | Upgrade
|
| Debt / FCF Ratio | 0.24 | 0.01 | 2.76 | 6.37 | 6.50 | - | Upgrade
|
| Asset Turnover | 0.81 | 0.82 | 0.73 | 0.71 | 0.68 | 0.56 | Upgrade
|
| Inventory Turnover | 6.10 | 5.99 | 5.42 | 4.81 | 2.30 | 2.06 | Upgrade
|
| Quick Ratio | 0.82 | 0.80 | 0.67 | 0.67 | 0.68 | 0.53 | Upgrade
|
| Current Ratio | 1.06 | 1.07 | 0.82 | 0.78 | 0.82 | 0.70 | Upgrade
|
| Return on Equity (ROE) | 13.03% | 13.17% | 7.54% | -15.72% | 2.75% | 23.21% | Upgrade
|
| Return on Assets (ROA) | 5.77% | 6.12% | 2.97% | 1.22% | 1.57% | -1.66% | Upgrade
|
| Return on Capital (ROIC) | 7.96% | 8.38% | 3.88% | 1.60% | 2.12% | -2.40% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.80% | 14.60% | 9.90% | 4.90% | 5.70% | - | Upgrade
|
| Earnings Yield | 4.32% | 4.10% | 2.18% | -5.22% | 0.70% | 5.69% | Upgrade
|
| FCF Yield | 5.42% | 6.13% | 4.43% | 4.09% | 3.75% | -0.44% | Upgrade
|
| Payout Ratio | 1.60% | 4.02% | 36.41% | - | 157.49% | 33.62% | Upgrade
|
| Buyback Yield / Dilution | -3.04% | -2.82% | -0.05% | -0.07% | 0.04% | 0.01% | Upgrade
|
| Total Shareholder Return | -3.04% | -2.82% | -0.05% | -0.07% | 0.04% | 0.01% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.